Macitentan
Definition: Macitentan, sold under the brand name Opsumit, is an endothelin receptor antagonist developed by Actelion and approved for the treatment of pulmonary arterial hypertension (PAH). Macitentan is a dual endothelin receptor antagonist, meaning that it acts as an antagonist of two endothelin (ET) receptor subtypes, ETA and ETB. source: Wikipedia
- ID
- 710283008
- ID date
- 29 Sep 2015
- Previous ID
- 23676511000001104
- Name
- Macitentan